Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Silibinin inhibits acetylcholinesterase activity and amyloid β peptide aggregation: a dual-target drug for the treatment of Alzheimer’s disease
Songwei Duan, Xiaoyin Guan, Runxuan Lin, et al.
Neurobiology of Aging (2015) Vol. 36, Iss. 5, pp. 1792-1807
Closed Access | Times Cited: 113

Showing 26-50 of 113 citing articles:

Silibinin rescues learning and memory deficits by attenuating microglia activation and preventing neuroinflammatory reactions in SAMP8 mice
Ge Jin, Dafeng Bai, Shiliang Yin, et al.
Neuroscience Letters (2016) Vol. 629, pp. 256-261
Closed Access | Times Cited: 60
Nutraceuticals: An emerging therapeutic approach against the pathogenesis of Alzheimer’s disease
Pritam Sadhukhan, Sukanya Saha, Sayanta Dutta, et al.
Pharmacological Research (2017) Vol. 129, pp. 100-114
Closed Access | Times Cited: 59
Geniposide ameliorates cognitive deficits by attenuating the cholinergic defect and amyloidosis in middle-aged Alzheimer model mice
Chunhui Zhao, Haijing Zhang, Hang Li, et al.
Neuropharmacology (2016) Vol. 116, pp. 18-29
Closed Access | Times Cited: 53
Silibinin ameliorates Aβ25-35-induced memory deficits in rats by modulating autophagy and attenuating neuroinflammation as well as oxidative stress
Xiao-Yu Song, Biao Zhou, Lingyu Cui, et al.
Neurochemical Research (2016) Vol. 42, Iss. 4, pp. 1073-1083
Closed Access | Times Cited: 53
Silymarin and neurodegenerative diseases: Therapeutic potential and basic molecular mechanisms
Rasool Haddadi, Zahra Shahidi, Shahla Eyvari-Brooshghalan
Phytomedicine (2020) Vol. 79, pp. 153320-153320
Closed Access | Times Cited: 44
Medicinal plants and bioactive natural products as inhibitors of NLRP3 inflammasome
Mohammad Bagherniya, Hamed Khedmatgozar, Omid Fakheran, et al.
Phytotherapy Research (2021) Vol. 35, Iss. 9, pp. 4804-4833
Closed Access | Times Cited: 34
In Silico Interactions of Natural and Synthetic Compounds with Key Proteins Involved in Alzheimer’s Disease: Prospects for Designing New Therapeutics Compound
Mehran Ebrahimi Shah-abadi, Armin Ariaei, Fatemeh Moradi, et al.
Neurotoxicity Research (2023) Vol. 41, Iss. 5, pp. 408-430
Open Access | Times Cited: 16
Enhancement of neural regeneration as a therapeutic strategy for Alzheimer's disease (Review)
Junyan Gao, Liping Li
Experimental and Therapeutic Medicine (2023) Vol. 26, Iss. 3
Open Access | Times Cited: 13
Curcumin hybrid molecules for the treatment of Alzheimer's disease: Structure and pharmacological activities
Wei-Biao Zang, Huiling Wei, Weiwei Zhang, et al.
European Journal of Medicinal Chemistry (2023) Vol. 265, pp. 116070-116070
Closed Access | Times Cited: 13
DL0410 Ameliorates Memory and Cognitive Impairments Induced by Scopolamine via Increasing Cholinergic Neurotransmission in Mice
Wenwen Lian, Jiansong Fang, Lvjie Xu, et al.
Molecules (2017) Vol. 22, Iss. 3, pp. 410-410
Open Access | Times Cited: 48
Multi-Target Screening and Experimental Validation of Natural Products from Selaginella Plants against Alzheimer's Disease
Yin-Hua Deng, Ningning Wang, Zhen‐Xing Zou, et al.
Frontiers in Pharmacology (2017) Vol. 8
Open Access | Times Cited: 44
D-Carvone inhibit cerebral ischemia/reperfusion induced inflammatory response TLR4/NLRP3 signaling pathway
Mengyuan Dai, Lixiu Wu, Kunqiang Yu, et al.
Biomedicine & Pharmacotherapy (2020) Vol. 132, pp. 110870-110870
Open Access | Times Cited: 39
Exploring the Potential of Therapeutic Agents Targeted towards Mitigating the Events Associated with Amyloid-β Cascade in Alzheimer’s Disease
Tapan Behl, Ishnoor Kaur, Ovidiu Frăţilă, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 20, pp. 7443-7443
Open Access | Times Cited: 38
Silibinin Alleviates the Learning and Memory Defects in Overtrained Rats Accompanying Reduced Neuronal Apoptosis and Senescence
Bo Liu, Weiwei Liu, Panwen Liu, et al.
Neurochemical Research (2019) Vol. 44, Iss. 8, pp. 1818-1829
Closed Access | Times Cited: 37
High-fidelity imaging of amyloid-beta deposits with an ultrasensitive fluorescent probe facilitates the early diagnosis and treatment of Alzheimer's Disease
Rongrong Tao, Ning Wang, Tianruo Shen, et al.
Theranostics (2022) Vol. 12, Iss. 6, pp. 2549-2559
Open Access | Times Cited: 21
Silibinin Protects against H2O2-Induced Oxidative Damage in SH-SY5Y Cells by Improving Mitochondrial Function
Fangfang Tie, Yang-Yang Fu, Na Hu, et al.
Antioxidants (2022) Vol. 11, Iss. 6, pp. 1101-1101
Open Access | Times Cited: 20
Formulation and Characterization of Silibinin Entrapped Nano-Liquid Crystals for Activity against Aβ1-42 Neurotoxicity in In-Vivo Model
Ajit Singh, Debarati Rakshit, Ankit Kumar, et al.
AAPS PharmSciTech (2024) Vol. 25, Iss. 6
Closed Access | Times Cited: 4
Effects silymarin and rosuvastatin on amyloid-carriers level in dyslipidemic Alzheimer’s patients: A double-blind placebo-controlled randomized clinical trial
Auob Rustamzadeh, Nader Sadigh, Zahra Vahabi, et al.
IBRO Neuroscience Reports (2024) Vol. 17, pp. 108-121
Open Access | Times Cited: 4
Comparison Between Molecular Dynamics Potentials for Simulation of Graphene-Based Nanomaterials for Biomedical Applications
Laurentius Ivan Ageng Marhaendra, Yudi Rosandi, Amirah Mohd Gazzali, et al.
Drug Development and Industrial Pharmacy (2025), pp. 1-16
Closed Access
Targeting NAD + degradation: The therapeutic potential of flavonoids for Alzheimer's disease and cognitive frailty
Qingwei Ruan, Jian Ruan, Weibin Zhang, et al.
Pharmacological Research (2017) Vol. 128, pp. 345-358
Closed Access | Times Cited: 38
Insights into the inhibitory mechanism of a resveratrol and clioquinol hybrid against Aβ42 aggregation and protofibril destabilization: A molecular dynamics simulation study
Rajneet Kaur Saini, Suniba Shuaib, Deepti Goyal, et al.
Journal of Biomolecular Structure and Dynamics (2018) Vol. 37, Iss. 12, pp. 3183-3197
Closed Access | Times Cited: 38
The codrug approach for facilitating drug delivery and bioactivity
Ibrahim A. Aljuffali, Chwan‐Fwu Lin, Chun‐Han Chen, et al.
Expert Opinion on Drug Delivery (2016) Vol. 13, Iss. 9, pp. 1311-1325
Closed Access | Times Cited: 36
Rosuvastatin ameliorates cognitive impairment in rats fed with high-salt and cholesterol diet via inhibiting acetylcholinesterase activity and amyloid beta peptide aggregation
Ibraheem Husain, Mymoona Akhtar, M. Z. Abdin, et al.
Human & Experimental Toxicology (2017) Vol. 37, Iss. 4, pp. 399-411
Closed Access | Times Cited: 36
Scrutiny of the mechanism of small molecule inhibitor preventing conformational transition of amyloid-β42 monomer: insights from molecular dynamics simulations
Suniba Shuaib, Bhupesh Goyal
Journal of Biomolecular Structure and Dynamics (2017) Vol. 36, Iss. 3, pp. 663-678
Closed Access | Times Cited: 35
Prevention of Alzheimer's disease by treating mild cognitive impairment with combinations chosen from eight available drugs
Jeffrey Fessel
Alzheimer s & Dementia Translational Research & Clinical Interventions (2019) Vol. 5, Iss. 1, pp. 780-788
Open Access | Times Cited: 33

Scroll to top